Notice Number: NOT-MH-18-052
Key Dates
Release Date: September 24, 2018
PAR-18-269
Issued by
National Institute of Mental Health (NIMH)
Purpose
The purpose of this Notice to clarify the Application Types allowed in PAR-18-269, Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional).
Currently reads
Section II. Award Information
Application Types Allowed
New (Phase I, Fast Track)
Renewal (Phase II* Direct Phase II not allowed)
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Modified to read
Section II. Award Information
Application Types Allowed
New (Phase I, Fast Track)
Renewal (Phase II* Direct Phase II not allowed)
Resubmission (all phases)
Revision
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Section V. Application Review Information
Currently reads
Resubmission
Not Applicable
Revision
Not Applicable
Modified to read
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Revisions
For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Adam Haim, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-435-3593
Email: haima@mail.nih.gov
and Human Services (HHS)
